TerrAscend Corp. to Attend Life Sciences Fall Conference in New York
News provided byTerrAscend Corp · 1 min read
TORONTO, Sept. 04, 2026 /CourierPR/ -- TerrAscend Corp., a prominent North American cannabis operator, will send its executive management team to participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference in New York City on September 9, 2026. Jason Wild, the company’s Executive Chairman, and Ziad Ghanem, Chief Executive Officer, will host one-on-one meetings with investors and industry professionals during the event.
TerrAscend Corp. is a TSX-listed cannabis company with a significant presence across North America. The firm operates in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary TerrAscend Growth Corp. Additionally, TerrAscend has retail operations in Canada, operating The Apothecarium and other dispensaries. The company also manages large-scale cultivation, processing, and manufacturing facilities in its core markets, ensuring consistent and high-quality cannabis products for both medical and recreational use.
TerrAscend’s diverse portfolio includes several brands and businesses, such as The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One, and Valhalla. These brands and businesses complement TerrAscend’s core operations, enhancing its market position and product offerings.
The ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference is expected to attract a wide range of investors and industry experts, providing TerrAscend with valuable networking and business development opportunities. The one-on-one meetings hosted by Wild and Ghanem will allow the company to engage in detailed discussions with key stakeholders, further solidifying its standing in the cannabis industry.